Trisalus Life Sciences, Inc.

TLSI

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/05/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report09/22/26 8-KCurrent report08/06/26 8-KCurrent report05/14/26 8-KCurrent report05/12/26 8-KCurrent report04/29/26

Prospectuses and Registrations

S-8Registration of securities for employees03/10/26 424B5Prospectus supplement02/26/26 424B5Prospectus supplement02/20/26 424B5Prospectus supplement02/19/26 S-3Shelf registration11/13/25

Proxies

DEF 14ADefinitive proxy03/31/26 DEFA14AAdditional proxy materials03/31/26 DEF 14ADefinitive proxy04/30/25 DEF 14ADefinitive proxy07/19/24 DEFA14AAdditional proxy materials08/02/23

Ownership

Form 4Insider transaction10/07/26 Form 4Insider transaction10/07/26 Form 4Insider transaction10/07/26 Form 4Insider transaction10/07/26 SC 13G/ABeneficial ownership (amended)07/07/26

Other

ARSAnnual report to shareholders03/31/26 EFFECTRequest for effectiveness12/04/25 CORRESPCorrespondence with the SEC12/02/25 SC TO-I/ASC TO-I/A07/25/25 EFFECTRequest for effectiveness07/22/25